Results 21 to 30 of about 1,055,250 (236)

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan

Saudi Pharmaceutical Journal, 2023
Background: Geriatric cancer patients are susceptible to adverse drug events due to the complexity of their chemotherapy regimens and collateral treatments for their comorbid conditions. Prescribing medications with anticholinergic burden characteristics
Ahmad Al-Azayzih, Anan S. Jarab, Enas Bani-Ahmad, Saja Smadi, Zelal Kharaba, Khalid A. Al-Kubaisi   +5 more
doaj   +1 more source

Anticholinergic drugs and risk of dementia: case-control study. [PDF]

BMJ, 2018
Objectives: To estimate the association between the duration and level of exposure to different classes of anticholinergic drugs and subsequent incident dementia. Design: Case-control study.
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM.   +15 more
europepmc   +2 more sources

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.

PLoS ONE, 2021
IntroductionAnticholinergic adverse effects (AEs) are a problem for elderly people. This study aimed to answer the following questions. First, is an analysis of anticholinergic AEs using spontaneous adverse drug event databases possible?
Junko Nagai, Yoichi Ishikawa
doaj   +1 more source

Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review

BMC Pharmacology and Toxicology, 2022
Purpose The aim of this work was to investigate the association between anticholinergic burden or anticholinergic drug use and xerostomia and/or xerophtalmia in elderly through a systematic review of the published literature. Methods A search was carried
E. Prado-Mel, P. Ciudad-Gutiérrez, H. Rodríguez-Ramallo, S. Sánchez-Fidalgo, B. Santos-Ramos, A. M. Villalba-Moreno   +5 more
doaj   +1 more source

A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Anticholinergic burden potentially increases the risk of fracture. Although there are various anticholinergic burden scales, little is known about the inter-scale compatibility regarding the relationship of anticholinergic burden with fracture
Yukari Ogawa, Toshinori Hirai, Kiyoshi Mihara   +2 more
doaj   +1 more source

Use of anticholinergic drugs in seniors [PDF]

, 2021
Introduction: In the past decades, the representation of seniors is increasing and the knowledge and the approaches to geriatrics and gerontology are more and more important.
Havrošová, Andrea
core  

An anticholinergic burden score for German prescribers: score development

BMC Geriatrics, 2018
Background Anticholinergic drugs put elderly patients at a higher risk for falls, cognitive decline, and delirium as well as peripheral adverse reactions like dry mouth or constipation.
Esther Katharina Kiesel, Yvonne Marina Hopf, Michael Drey   +2 more
doaj   +1 more source

Drugs with anticholinergic side-effects in primary care [PDF]

, 2015
Background: Anticholinergic drugs in elderly people have been associated with some serious side.effects. Patients in Turkey tend to attend primary care centers to have prescriptions of the drugs they chronically use.
Binen, E, Keskin, A, Yayla, EM, Yavuz, E, Bilge, U   +4 more
core   +1 more source

Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden

International Medical Case Reports Journal, 2023
Koichi Nisijima1,2 1Department of Psychiatry, Nasukougen Hospital, Nasu-machi, Tochigi, Japan; 2Department of Psychiatry, Jichi Medical University, Shimotuke City, Tochigi, JapanCorrespondence: Koichi Nisijima, Shimotuke City, Tochigi, 329-0433, Japan ...
Nisijima K
doaj  

Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia

, 2021
Objectives: To investigate the associations between central anticholinergic burden and mortality, hospitalization, and cognitive impairment in people with dementia prescribed anticholinergic drugs for urinary symptoms. Design: Retrospective cohort study.
Bishara, Delia, Harwood, Daniel, Sauer, Justin, Mueller, Christoph; id_orcid, Funnell, Nicola, Perera, Gayan, Taylor, David; id_orcid, Stewart, Robert   +7 more
core   +1 more source